CN112661820B - Rhizobium tianshanense transcription regulation protein MsiR mutant protein and application thereof in canavanine biosensor - Google Patents
Rhizobium tianshanense transcription regulation protein MsiR mutant protein and application thereof in canavanine biosensor Download PDFInfo
- Publication number
- CN112661820B CN112661820B CN202011637703.7A CN202011637703A CN112661820B CN 112661820 B CN112661820 B CN 112661820B CN 202011637703 A CN202011637703 A CN 202011637703A CN 112661820 B CN112661820 B CN 112661820B
- Authority
- CN
- China
- Prior art keywords
- protein
- msir
- canavanine
- mutein
- mutant protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- FSBIGDSBMBYOPN-VKHMYHEASA-N L-canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 title claims abstract description 79
- FSBIGDSBMBYOPN-UHFFFAOYSA-N O-guanidino-DL-homoserine Natural products OC(=O)C(N)CCON=C(N)N FSBIGDSBMBYOPN-UHFFFAOYSA-N 0.000 title claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 57
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 44
- 108010021466 Mutant Proteins Proteins 0.000 title claims abstract description 31
- 102000008300 Mutant Proteins Human genes 0.000 title claims abstract description 31
- 230000033228 biological regulation Effects 0.000 title abstract description 22
- 238000013518 transcription Methods 0.000 title abstract description 20
- 230000035897 transcription Effects 0.000 title abstract description 20
- 241001534001 Mesorhizobium tianshanense Species 0.000 title description 12
- 235000018102 proteins Nutrition 0.000 claims abstract description 39
- 241000589180 Rhizobium Species 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 12
- 235000001014 amino acid Nutrition 0.000 claims abstract description 11
- 210000004899 c-terminal region Anatomy 0.000 claims abstract description 8
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 5
- 235000004279 alanine Nutrition 0.000 claims abstract description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 4
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000013612 plasmid Substances 0.000 claims description 19
- 239000013598 vector Substances 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 12
- 108091033319 polynucleotide Proteins 0.000 claims description 11
- 102000040430 polynucleotide Human genes 0.000 claims description 11
- 239000002157 polynucleotide Substances 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 9
- 101000709520 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) Atypical response regulator protein ChxR Proteins 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 238000010276 construction Methods 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- 239000002054 inoculum Substances 0.000 claims 1
- 239000007160 ty medium Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 238000012216 screening Methods 0.000 abstract description 7
- 239000012636 effector Substances 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 13
- 230000001105 regulatory effect Effects 0.000 description 9
- 102000034356 gene-regulatory proteins Human genes 0.000 description 6
- 108091006104 gene-regulatory proteins Proteins 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000000111 isothermal titration calorimetry Methods 0.000 description 4
- 238000003259 recombinant expression Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 108010068265 aspartyltyrosine Proteins 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 2
- GIVWETPOBCRTND-DCAQKATOSA-N Arg-Gln-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GIVWETPOBCRTND-DCAQKATOSA-N 0.000 description 2
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 2
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000589174 Bradyrhizobium japonicum Species 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- LNVILFYCPVOHPV-IHPCNDPISA-N His-Trp-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O LNVILFYCPVOHPV-IHPCNDPISA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- RFEXGCASCQGGHZ-STQMWFEESA-N Phe-Gly-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O RFEXGCASCQGGHZ-STQMWFEESA-N 0.000 description 2
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 2
- XGZBEGGGAUQBMB-KJEVXHAQSA-N Tyr-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=C(C=C2)O)N)O XGZBEGGGAUQBMB-KJEVXHAQSA-N 0.000 description 2
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 2
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 2
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- YEVZMOUUZINZCK-LKTVYLICSA-N Ala-Glu-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O YEVZMOUUZINZCK-LKTVYLICSA-N 0.000 description 1
- NJWJSLCQEDMGNC-MBLNEYKQSA-N Ala-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C)N)O NJWJSLCQEDMGNC-MBLNEYKQSA-N 0.000 description 1
- NYDBKUNVSALYPX-NAKRPEOUSA-N Ala-Ile-Arg Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NYDBKUNVSALYPX-NAKRPEOUSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- LDLSENBXQNDTPB-DCAQKATOSA-N Ala-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LDLSENBXQNDTPB-DCAQKATOSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 1
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 1
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 1
- GMFAGHNRXPSSJS-SRVKXCTJSA-N Arg-Leu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GMFAGHNRXPSSJS-SRVKXCTJSA-N 0.000 description 1
- XRLOBFSLPCHYLQ-ULQDDVLXSA-N Arg-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XRLOBFSLPCHYLQ-ULQDDVLXSA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 1
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- FRSGNOZCTWDVFZ-ACZMJKKPSA-N Asp-Asp-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O FRSGNOZCTWDVFZ-ACZMJKKPSA-N 0.000 description 1
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 1
- QPDUWAUSSWGJSB-NGZCFLSTSA-N Asp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N QPDUWAUSSWGJSB-NGZCFLSTSA-N 0.000 description 1
- 241000589173 Bradyrhizobium Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- LRZPRGJXAZFXCR-DCAQKATOSA-N Cys-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N LRZPRGJXAZFXCR-DCAQKATOSA-N 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- UWZLBXOBVKRUFE-HGNGGELXSA-N Gln-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N UWZLBXOBVKRUFE-HGNGGELXSA-N 0.000 description 1
- ORYMMTRPKVTGSJ-XVKPBYJWSA-N Gln-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O ORYMMTRPKVTGSJ-XVKPBYJWSA-N 0.000 description 1
- HDUDGCZEOZEFOA-KBIXCLLPSA-N Gln-Ile-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N)N HDUDGCZEOZEFOA-KBIXCLLPSA-N 0.000 description 1
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 1
- ZBKUIQNCRIYVGH-SDDRHHMPSA-N Gln-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N ZBKUIQNCRIYVGH-SDDRHHMPSA-N 0.000 description 1
- TWIAMTNJOMRDAK-GUBZILKMSA-N Gln-Lys-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O TWIAMTNJOMRDAK-GUBZILKMSA-N 0.000 description 1
- ZGHMRONFHDVXEF-AVGNSLFASA-N Gln-Ser-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZGHMRONFHDVXEF-AVGNSLFASA-N 0.000 description 1
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 1
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 1
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 1
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 1
- DVLZZEPUNFEUBW-AVGNSLFASA-N Glu-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N DVLZZEPUNFEUBW-AVGNSLFASA-N 0.000 description 1
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 1
- OCJRHJZKGGSPRW-IUCAKERBSA-N Glu-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O OCJRHJZKGGSPRW-IUCAKERBSA-N 0.000 description 1
- HGJREIGJLUQBTJ-SZMVWBNQSA-N Glu-Trp-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O HGJREIGJLUQBTJ-SZMVWBNQSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- YZACQYVWLCQWBT-BQBZGAKWSA-N Gly-Cys-Arg Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YZACQYVWLCQWBT-BQBZGAKWSA-N 0.000 description 1
- ICUTTWWCDIIIEE-BQBZGAKWSA-N Gly-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN ICUTTWWCDIIIEE-BQBZGAKWSA-N 0.000 description 1
- HHRODZSXDXMUHS-LURJTMIESA-N Gly-Met-Gly Chemical compound CSCC[C@H](NC(=O)C[NH3+])C(=O)NCC([O-])=O HHRODZSXDXMUHS-LURJTMIESA-N 0.000 description 1
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 1
- WSWWTQYHFCBKBT-DVJZZOLTSA-N Gly-Thr-Trp Chemical compound C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O WSWWTQYHFCBKBT-DVJZZOLTSA-N 0.000 description 1
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 1
- ULRFSEJGSHYLQI-YESZJQIVSA-N His-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CN=CN3)N)C(=O)O ULRFSEJGSHYLQI-YESZJQIVSA-N 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- BOTVMTSMOUSDRW-GMOBBJLQSA-N Ile-Arg-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O BOTVMTSMOUSDRW-GMOBBJLQSA-N 0.000 description 1
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 1
- XMYURPUVJSKTMC-KBIXCLLPSA-N Ile-Ser-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N XMYURPUVJSKTMC-KBIXCLLPSA-N 0.000 description 1
- AUIYHFRUOOKTGX-UKJIMTQDSA-N Ile-Val-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N AUIYHFRUOOKTGX-UKJIMTQDSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- -1 L-canavanine small molecules Chemical class 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- JUWJEAPUNARGCF-DCAQKATOSA-N Leu-Arg-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JUWJEAPUNARGCF-DCAQKATOSA-N 0.000 description 1
- TWQIYNGNYNJUFM-NHCYSSNCSA-N Leu-Asn-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O TWQIYNGNYNJUFM-NHCYSSNCSA-N 0.000 description 1
- VPKIQULSKFVCSM-SRVKXCTJSA-N Leu-Gln-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPKIQULSKFVCSM-SRVKXCTJSA-N 0.000 description 1
- RSFGIMMPWAXNML-MNXVOIDGSA-N Leu-Gln-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RSFGIMMPWAXNML-MNXVOIDGSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 1
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 1
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 description 1
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 1
- ODRREERHVHMIPT-OEAJRASXSA-N Leu-Thr-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ODRREERHVHMIPT-OEAJRASXSA-N 0.000 description 1
- SEOXPEFQEOYURL-PMVMPFDFSA-N Leu-Tyr-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O SEOXPEFQEOYURL-PMVMPFDFSA-N 0.000 description 1
- IHITVQKJXQQGLJ-LPEHRKFASA-N Met-Asn-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N IHITVQKJXQQGLJ-LPEHRKFASA-N 0.000 description 1
- AETNZPKUUYYYEK-CIUDSAMLSA-N Met-Glu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O AETNZPKUUYYYEK-CIUDSAMLSA-N 0.000 description 1
- MHQXIBRPDKXDGZ-ZFWWWQNUSA-N Met-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 MHQXIBRPDKXDGZ-ZFWWWQNUSA-N 0.000 description 1
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 1
- VQILILSLEFDECU-GUBZILKMSA-N Met-Pro-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O VQILILSLEFDECU-GUBZILKMSA-N 0.000 description 1
- PCTFVQATEGYHJU-FXQIFTODSA-N Met-Ser-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O PCTFVQATEGYHJU-FXQIFTODSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- BBDSZDHUCPSYAC-QEJZJMRPSA-N Phe-Ala-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BBDSZDHUCPSYAC-QEJZJMRPSA-N 0.000 description 1
- ULECEJGNDHWSKD-QEJZJMRPSA-N Phe-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 ULECEJGNDHWSKD-QEJZJMRPSA-N 0.000 description 1
- CZQZSMJXFGGBHM-KKUMJFAQSA-N Phe-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O CZQZSMJXFGGBHM-KKUMJFAQSA-N 0.000 description 1
- YUPRIZTWANWWHK-DZKIICNBSA-N Phe-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N YUPRIZTWANWWHK-DZKIICNBSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 1
- HRIXMVRZRGFKNQ-HJGDQZAQSA-N Pro-Thr-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HRIXMVRZRGFKNQ-HJGDQZAQSA-N 0.000 description 1
- WWXNZNWZNZPDIF-SRVKXCTJSA-N Pro-Val-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 WWXNZNWZNZPDIF-SRVKXCTJSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- IUXGJEIKJBYKOO-SRVKXCTJSA-N Ser-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N IUXGJEIKJBYKOO-SRVKXCTJSA-N 0.000 description 1
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- WNDUPCKKKGSKIQ-CIUDSAMLSA-N Ser-Pro-Gln Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O WNDUPCKKKGSKIQ-CIUDSAMLSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- DKGRNFUXVTYRAS-UBHSHLNASA-N Ser-Ser-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DKGRNFUXVTYRAS-UBHSHLNASA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- UKBSDLHIKIXJKH-HJGDQZAQSA-N Thr-Arg-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UKBSDLHIKIXJKH-HJGDQZAQSA-N 0.000 description 1
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 1
- RKDFEMGVMMYYNG-WDCWCFNPSA-N Thr-Gln-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O RKDFEMGVMMYYNG-WDCWCFNPSA-N 0.000 description 1
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 1
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 1
- DNCUODYZAMHLCV-XGEHTFHBSA-N Thr-Pro-Cys Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N)O DNCUODYZAMHLCV-XGEHTFHBSA-N 0.000 description 1
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 1
- KERCOYANYUPLHJ-XGEHTFHBSA-N Thr-Pro-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O KERCOYANYUPLHJ-XGEHTFHBSA-N 0.000 description 1
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 1
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- YVXIAOOYAKBAAI-SZMVWBNQSA-N Trp-Leu-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 YVXIAOOYAKBAAI-SZMVWBNQSA-N 0.000 description 1
- UQHPXCFAHVTWFU-BVSLBCMMSA-N Trp-Phe-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O UQHPXCFAHVTWFU-BVSLBCMMSA-N 0.000 description 1
- KEANSLVUGJADPN-LKTVYLICSA-N Tyr-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N KEANSLVUGJADPN-LKTVYLICSA-N 0.000 description 1
- KHCSOLAHNLOXJR-BZSNNMDCSA-N Tyr-Leu-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHCSOLAHNLOXJR-BZSNNMDCSA-N 0.000 description 1
- CDBXVDXSLPLFMD-BPNCWPANSA-N Tyr-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDBXVDXSLPLFMD-BPNCWPANSA-N 0.000 description 1
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 1
- COYSIHFOCOMGCF-WPRPVWTQSA-N Val-Arg-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-WPRPVWTQSA-N 0.000 description 1
- HZYOWMGWKKRMBZ-BYULHYEWSA-N Val-Asp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HZYOWMGWKKRMBZ-BYULHYEWSA-N 0.000 description 1
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 1
- FXVDGDZRYLFQKY-WPRPVWTQSA-N Val-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C FXVDGDZRYLFQKY-WPRPVWTQSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- ZXYPHBKIZLAQTL-QXEWZRGKSA-N Val-Pro-Asp Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N ZXYPHBKIZLAQTL-QXEWZRGKSA-N 0.000 description 1
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108010074082 phenylalanyl-alanyl-lysine Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention provides a rhizobium tiansiense transcription regulation protein MsiR mutant protein and application thereof in a canavanine biosensor, wherein the mutant protein is an unnatural protein and has the capability of specifically responding to canavanine, and the mutant protein is mutated in 1 core amino acid related to combination of the wild MsiR and the canavanine: the 133 th site is mutated from aspartic acid (D) to alanine (A), the protein sequence of the mutant protein is shown as SEQ ID NO.1, the nucleotide sequence is shown as SEQ ID NO.2, the mutant protein of the invention is improved by 2 times compared with the wild type fluorescence value responding to canavanine, and the binding affinity of the MsiR mutant protein C-terminal effector binding region and the canavanine is improved by 1.5 times; meanwhile, the regulation activity of the MsiR transcription regulation protein is improved by screening the mutant protein of the protein.
Description
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to a tianshan rhizobium transcription regulation protein MsiR mutant protein and application thereof in a canavanine biosensor.
Background
Canavanine is an unnatural amino acid isolated from canavanine and widely exists in leguminous plants and seeds thereof, the structure of the canavanine is similar to arginine, so that the canavanine can replace arginine to synthesize protein, the canavanine can be mistakenly doped into newly synthesized protein in the protein synthesis process, the normal metabolic reaction of RNA and DNA is interfered, the synthesis of normal protein and the normal metabolism of arginine are influenced, the canavanine can be widely applied to the agricultural and pharmaceutical industries, and due to the difference of the structures of the canavanine and the arginine, the function of the formed protein is abnormal, the protein is inactivated, and the anabolic activity is realized, so that the canavanine is very important for quickly detecting the canavanine.
The slow-growing type Tianshan rhizobia can symbiotically nodulate and fix nitrogen at the root of the liquorice, and provide a nitrogen source required by plant growth. The establishment of such symbiotic relationships relies on a complex communication between rhizobia and host plants, where the MsiAR system, an export system of canavanine, is present in the rhizobium of Tianshan, and is capable of specifically recognizing intracellular canavanine, and the MsiR protein is capable of initiatingmsiAExpression of the gene in turn secretes intracellular canavanine to the outside of the cell, which acts as a co-inducer.
Leguminous plants have long evolved to use canavanine as a "biochemical weapon" for protection against herbivorous insects and animals, as well as against harmful microorganisms. Related researches also show that the canavanine has anti-tumor activity, and the development of a method for quickly and efficiently detecting the canavanine has important value for researching the physiological function, the synthetic mechanism and the anti-cancer mechanism of the canavanine. The currently reported detection methods of L-canavanine include a chemical spectrophotometer detection method, a high performance liquid chromatography method, a capillary electrophoresis method, an amino acid analysis method, a nuclear magnetic resonance detection method and the like, but the methods have the defects of complex pretreatment, low sensitivity, low specificity, complex operation, long time consumption, low flux and the like.
The Transcription regulation Factor (Transcription Factor) is an important regulation protein in a microorganism body, a specific metabolite is used as a ligand, downstream genes are regulated after the ligand is combined with a promoter region of the regulated protein, and the amount of the required ligand has positive correlation with the regulation effect in a certain range. Based on the above principle, the transcription regulatory factor in the microorganism may be designed as a Biosensor (Biosensor) capable of recognizing a specific target metabolite, thereby enabling rapid detection of the target metabolite. Compared with the traditional rational design, the method has the advantages of high detection speed, high sensitivity and the like, and related reports of the L-canavanine single-cell biosensor do not exist at present, so that a real-time, accurate and sensitive canavanine detection method is urgently needed.
Through extensive and intensive research, the inventor screens out key amino acid sites capable of remarkably improving the transcriptional regulation activity of the MsiR mutant protein on canavanine through a large amount of screening, the inventor finds that after the key sites in the wild-type MsiR mutant protein are modified, the fluorescence value of the transcriptional regulation protein MsiR mutant protein responding to the canavanine is improved by two times compared with the wild-type MsiR mutant protein, and an ITC result shows that the mutation greatly improves the affinity of the MsiR protein and the canavanine, and through retrieval, a patent publication document related to the patent application is not found.
Disclosure of Invention
Aiming at the defects of the prior art, the invention is based on the transcription regulation and control factor MsiR, the concentration of L-canavanine is coupled with the fluorescence intensity, a biosensor capable of detecting the concentration of L-canavanine is constructed, the specificity quantitative detection of the L-canavanine can be realized, and the regulation and control activity of the MsiR transcription regulation and control protein is improved by screening the mutant protein of the protein.
One of the objectives of the present invention is to provide a rhizobium tiansiense transcriptional regulatory protein MsiR mutein, wherein the mutein is a non-natural protein and has the ability to specifically respond to canavanine, and the mutein undergoes mutation in 1 core amino acid of wild-type MsiR associated with canavanine binding: aspartic acid (D) is mutated into alanine (A) at position 133, the protein sequence of the mutant protein is shown as SEQ ID NO.1, and the nucleotide sequence is shown as SEQ ID NO. 2.
Further, the transcription regulation protein MsiR is derived from bradyrhizobium japonicum in Tianshan mountain.
The other object of the present invention is to provide a polynucleotide, wherein the vector comprises the polynucleotide of claim 3, wherein the C-terminal nucleotide sequence encoded by the polynucleotide is shown in SEQ ID NO.3, and the C-terminal protein sequence encoded by the polynucleotide is shown in SEQ ID NO. 4.
Another object of the present invention is to provide two vectors comprising the polynucleotide of claim 3
The fourth object of the present invention is to provide two host cells comprising the vector of claim 4 or having the polynucleotide of claim 3 integrated into its genome.
The fifth object of the present invention is to provide a method for producing a mutein, comprising culturing the host cell of claim 5 under suitable conditions for expression to express the transcriptional regulator protein MsiR mutein; and/or isolating the transcriptional regulatory protein MsiR mutein.
The sixth purpose of the invention is to provide a method for constructing a canavanine single-cell biosensor, which comprises the following steps:
(1) based on the transcription regulation factor MsiR, by using slow rooting rhizomatous bacteria in Tianshan mountainmsiRConstructing PTCV141 and PTM5 plasmids by taking the gene knockout strain as a starting strain, wherein the PTCV141 is used for constructingmsiRA vector for gene mutation; PTM5 is obtained by cloning mCherry gene to the downstream of promoter Pmsia regulated by Msry protein, and is used for quantitatively detecting the influence of different Msry mutant proteins on Pmsia transcription regulation, so as to construct a screening strain TC4M302, wherein the expression condition of the msiA promoter is represented by the ratio of mCherry fluorescence value to OD600 nm;
(2) the constructed single-cell biosensor with coupled fluorescence signals and canavanine concentration detects the linear range of the single-cell biosensor, and the fluorescence signal intensity and the canavanine concentration have good linear relation under the canavanine concentration of 0 mmol/L to 5.68 mmol/L.
Furthermore, the canavanine single-cell biosensor consists of a transcription regulatory factor MsiR coding gene of the slow rhizobium in the source, a promoter region and a terminator region of the gene msiA in the slow rhizobium in the source, a red fluorescent protein coding gene mCherry and a plasmid skeleton pYC12 plasmid.
The seventh object of the present invention is to provide the use of the mutein of claim 1 for the construction of a biosensor in response to canavanine or for the detection of canavanine in vitro.
Further, the single-cell biosensor for detecting the concentration of L-canavanine comprises the following steps:
(1) pre-culturing rhizobium japonicum containing PTCV141 plasmid and PTM5 plasmid at 28 ℃ for more than 12 hours until entering stationary phase;
(2) inoculating the pre-cultured rhizobium tiansiense into a fresh TY culture medium containing L-canavanine with different concentrations in an inoculation amount of 1: 50;
(3) and (5) when the bacterial liquid OD600 is between 0.6 and 0.8, culturing for 48 to 72 hours, and then measuring the fluorescence intensity.
Compared with the prior art, the invention has the advantages and positive effects that: the mutein is prepared by transcriptional regulation protein MsiR of rhizobium tianschanicum from a wild type, amino acid at position 133 is mutated into alanine from aspartic acid (D), a biosensor capable of detecting the concentration of L-canavanine is constructed based on the transcriptional regulation factor MsiR, the specificity quantitative detection of the L-canavanine can be realized, the mutein is improved by 2 times compared with the fluorescent value of the response of the wild type to the canavanine, and the affinity of the combination of the C-end effector binding region of the MsiR mutein and the canavanine is improved by 1.5 times; meanwhile, the regulation activity of the MsiR transcription regulation protein is improved by screening the mutant protein of the protein.
Drawings
FIG. 1 is a schematic diagram of a single-cell biosensor for MsiR muteins according to the present invention;
FIG. 2 is an SDS-PAGE electropherogram of purified MsiR muteins according to the present invention;
FIG. 3 shows the expression of the msiR mutein msi A promoter according to the invention;
FIG. 4 shows the results of an isothermal titration calorimetry assay of the MsiR mutein MsiR (D133A) -CTD according to the invention with canavanine;
FIG. 5 is an experimental result of an isothermal titration calorimetry experimental determination of MsiR-CTD and canavanine according to the present invention;
FIG. 6 shows the results of isothermal titration calorimetry of the negative control buffer and canavanine of the present invention.
Detailed Description
The following detailed description of the embodiments of the present invention is provided for the purpose of illustration and not limitation, and should not be construed as limiting the scope of the invention.
The raw materials used in the invention are conventional commercial products unless otherwise specified; the methods used in the present invention are conventional in the art unless otherwise specified.
Example 1: preparation of recombinant expression plasmids and recombinant expression transformants of transcriptional regulatory proteins MsiR (MsiR1-297aa) and MsiR-CTD (MsiR83-297aa)
(1) MsiR-CTD (MsiR83-297aa) is the C end of a transcriptional regulatory protein MsiR, after the protein gene sequence of the MsiR-CTD (MsiR83-297aa) is synthesized, the protein gene sequence is connected to a pET21b empty vector (namely the vector), restriction enzymes BamHI and NdeI are used for double digestion overnight, then agarose gel electrophoresis purification and DNA kit recovery are carried out, the recovered digestion target fragment and the empty vector pET21b are connected for 12 hours at 4 ℃ under the action of T4 DNA ligase to obtain a recombinant plasmid pET21b-msiR-CTD, and the recombinant plasmid pET 21-b-msiR-CTD is further transformed into a competent cell BL21(DE3) to pick up a positive clone, namely, the recombinant expression transformant E, coli BL21(DE 3)/pET 21b-msiR-CTD is obtained.
(2) MsiR (MsiR1-297aa) is a complete sequence of a transcription regulatory protein MsiR, after the protein gene sequence of the MsiR (MsiR1-297aa) is synthesized, the protein gene sequence is connected to a pYC12 plasmid empty vector (namely the vector), restriction enzymes Hind3 and KpnI are used for double digestion overnight, and then agarose gel electrophoresis purification and DNA kit recovery are carried out,connecting the recovered enzyme digestion target fragment and an empty vector pYC12 plasmid at 4 ℃ for 12 hours under the action of T4 DNA ligase to obtain a recombinant plasmid pYC12 plasmid-msiR, and then converting the recombinant plasmid pYC12 plasmid-msiR into the recombinant plasmid pYC12 plasmid-msiRBW20767Coli (i.e., host cell) and selecting positive clone to obtain recombinant expression transformant E. coli BW 20767/pYC 12-msiR, i.e., PTCV 141.
Example 2: construction of transcription regulation protein MsiR for activity screening system of canavanine
Taking an msiR gene knockout strain of bradyrhizobium in TC4 Tianshan as an initial strain, introducing PTCV141 plasmid and PTM5 plasmid into Tianshan rhizobium (namely host cells) to construct a screened strain TC4 (PTCV 141 plasmid and PTM5 plasmid), wherein PTCV141 is a vector for constructing msiR gene mutation; PTM5 is obtained by cloning mCherry gene to the downstream of promoter PmsIA regulated by MsriR protein for quantitatively detecting the influence of different MsriR mutant proteins on PmsiA transcription regulation, and the expression condition of the msiA promoter is represented by the ratio of mCherry fluorescence value to OD600 nm.
Example 3: construction of regulatory protein MsiR and MsiR-CTD mutant
Carrying out comparison of protein homologous structures through an NCBI database, selecting 3FD3_ A with the highest similarity in the protein structure database as a template for homologous modeling, constructing a MsiR structure model by using DS Modeling2.5, selecting 10.0 amino acids in a substrate binding pocket, then carrying out molecular docking with L-canavanine small molecules, screening 10 mutant amino acids influencing substrate binding through the conservatism of amino acid sequences and the docking and typing condition, carrying out alanine mutation scanning, designing primer sequences aiming at the 10 mutant amino acids, wherein the primer sequences are shown in Table 1, carrying out PCR by using pET21b-msiR-CTD and PTCV141 as templates respectively and adopting a one-step method PCR, carrying out PCR by using high-fidelity polymerase, and the PCR reaction conditions are as follows: in a PCR reaction system with a total volume of 50. mu.L, 50-100 ng of template, 5. mu.l (2mM) of deoxyribonucleoside triphosphate (dNTP), 10. mu.l of 5 Xfast polymerase buffer, 1. mu.L of primer-F (10. mu.M), 1. mu.L of primer-R (10. mu.M) and 1. mu.L of FastPfu DNA polymerase were added, and sterilized distilled water was added to 50. mu.L. The PCR reaction program was set as: 2 min at 98 ℃ (30 s at 98 ℃, 30s at 58 ℃, 3min at 72 ℃), 35 cycles, 10 min at 72 ℃, and the product was stored at 4 ℃.
The PCR product was analyzed and verified by agarose gel electrophoresis, and digested for 4h at 37 ℃ with the addition of the restriction enzyme DpnI. Transfer of the digests into E. coliBL21(DE3) competent cells andBW20767and E.coli, respectively coating the Escherichia coli in plates containing ampicillin and gentamicin, placing the plates in an incubator at 37 ℃ for standing culture for about 12 hours, picking the obtained monoclonal colonies into a test tube containing 4ml of LB culture medium for culture, and sequencing corresponding genes.
TABLE 1
The mutant protein is mutated in 1 core amino acid of a wild-type transcription regulatory protein MsiR which is related to the binding of canavanine.
Example 4: construction of a mutant library of regulatory proteins MsiR
Constructing a 133-amino acid saturation mutant library of MsiR with enhanced transcriptional regulation activity according to the mutant protein alanine scanning result, and designing a mutation primer by adopting degenerate codon NNK, wherein the mutation primer comprises the following steps:
the upstream primer is as follows: 133-F: 5 'GGCTACGGTCTCgcggtatgNNKctggtcgtcgacggcgacgttca 3'
The downstream primer is: 133-R: 5 'GGCTACGGTCTCtaccgccgaatggctgcagcgcgga 3'
The PCR system and procedure were the same as in example 3, and the obtained monoclonal colonies were ligated with M.tianshanense, which had been transformed with PTM5 plasmid, to obtain a zygote, and the ligated colonies were picked up in a 96-well deep-well plate for culture, and the expressed proteins were screened for high-throughput regulatory activity, and the mutants with fluorescence values 2-fold higher than the wild type were subjected to corresponding gene sequencing.
Example 5: detection of regulatory Activity of mutant Strain
Selecting a mutant strain with improved regulation activity, selecting three clones of the mutant strain, a positive control wild strain 141TC4 and a negative control 12TC4 strain, inoculating the three clones into a 96-well plate, culturing for 4 days at 28 ℃ in a TY liquid culture medium, then inoculating the clones into TY liquid culture medium with L-canavanine concentrations of 0.1 ug/ml,10 ug/ml,100 ug/ml and 1000 ug/m respectively, wherein the inoculation ratio of the seed liquid is 1:100, when the bacterial liquid OD600 is 0.6-0.8, the mutant strain is cultured for 4 days at 28 ℃ to measure the fluorescence intensity, and the mCherry fluorescence value and the OD600 value are detected by an enzyme labeling instrument, and a multifunctional detector of a biotechnology company, the model of which is Synergy NEO2, is used, and the fluorescence intensity of the mutant strain is improved by more than 2 times compared with the positive control wild strain 141TC4 and the negative control 12TC4 according to be seen in figure 3.
Example 6: inducible expression and purification of regulatory protein MsiR-CTD (MsiR83-297aa) mutant
Preparing 50mL of seed liquid, wherein the culture medium is LB liquid culture medium (peptone 10g/L, yeast powder 5g/L, NaCl 10g/L), picking single colony of the genetically engineered bacteria by using an inoculating loop, inoculating into the culture medium, and culturing at 37 ℃ and 200rpm overnight. Transferring the seed liquid cultured overnight to a fermentation medium (LB medium) with the inoculation amount of 1%, culturing at 37 ℃ and 200rpm until the A is 6000.6-1.0, adding 0.5 mM IPTG, and inducing at 20 ℃ and 200rpm for 10-12 h. The thalli is collected by centrifugation at the temperature of 4 ℃ and the rpm of 5500, washed twice by sodium phosphate buffer solution (100mM, pH 7.0), crushed by a high-pressure homogenizer, centrifuged at 13000rpm to leave supernatant, purified and recovered by a metal affinity chromatography (nickel column) method, and the target protein is subjected to a desalting method to remove imidazole to obtain MsiR-CTD (MsiR83-297aa) mutant pure enzyme solution, and the result shows that the method can obtain a relatively pure protein mutant, and the purified protein has a single band, the molecular weight is 25KD and the purity is more than 95%.
Example 7: regulation protein MsiR mutant and determination of affinity of MsiR wild type C-terminal effector binding region and canavanine thereof
Isothermal titration calorimetry experiments were conducted at 25 ℃ using a MicroCal Auto-iTC200 isothermal titration calorimeter (GE Healthcare Life Sciences, USA). In the experiment, purified MsiR-CTD and MsiR (D133A) -CTD were first desalted into 20 mM phosphate buffer pH 8.0, 300 mM NaCl, 200mM KCl, 10% glycerol, 5mM beta-mercaptoethanol using HiTrap desaling column. The protein was then concentrated to 50uM, followed by dissolution of canavanine to 1mmol in desalting buffer, followed by titration of the protein with small molecules, at a volume of 0.4ul for each experiment, for a titration time of 0.8s, with a time interval of 120s for each titration. The affinity of MsiR-CTD, MsiR (D133A) -CTD and control buffer for small molecule canavanine was determined using an isothermal calorimeter. The analysis of the binding of small molecules to proteins by the software ORIGIN version 7.0 belongs to a single site binding model and common thermodynamic parameters were calculated (see table 2). From these results, it was found that the affinity of the C-terminal effector binding region of the MsiR mutein for binding to canavanine was increased by 1.5-fold.
TABLE 2 ITC measurement results of thermodynamic scanning
In the table: ka. Kd is the measured affinity, Δ G is the entropy change, Δ H is the enthalpy change, and Δ ST is the hydrophobic force.
The invention constructs a single-cell biosensor with coupled fluorescence signals and canavanine concentration based on the transcription regulatory factor MsiR mutant protein, detects the linear range of the single-cell biosensor, and has good linear relation between the fluorescence signal intensity and the canavanine concentration under the canavanine concentration of 0 mmol/L to 5.68 mmol/L. Compared with a wild type fluorescent value responding to canavanine, the transcriptional regulatory protein MsiR mutant protein disclosed by the invention has a two-fold increase, and the binding affinity of a C-terminal effector binding region of the MsiR mutant protein and the canavanine is increased by 1.5 times.
Although the embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that: various substitutions, changes and modifications are possible without departing from the spirit and scope of the invention and the appended claims, and therefore the scope of the invention is not limited to the disclosure of the embodiments and the accompanying drawings.
Sequence listing
<110> institute of biotechnology for Tianjin industry of Chinese academy of sciences
<120> transcription regulation protein MsiR mutant protein of rhizobium tianshanense and application thereof in canavanine biosensor
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 297
<212> PRT
<213> Mesorhizobium tianshanense (Mesorhizobium tianshanense)
<400> 1
Met Leu Asp Tyr Pro Ala Leu Arg Ala Val Ala Thr Ile Val Gln Thr
1 5 10 15
Gly Ser Phe Glu Arg Ala Ala Thr Ala Leu Asn Val Thr Pro Ser Ala
20 25 30
Ile Ser Gln Arg Val Lys Gln Leu Glu Glu Arg Leu Gly Val Ile Leu
35 40 45
Ile Val Arg Gly Thr Pro Cys Thr Ala Thr Glu Lys Gly Glu Trp Leu
50 55 60
Cys Arg His Met Glu Asn Val Gly Met Leu Glu Ala Glu Leu Phe Gly
65 70 75 80
Gln Leu Pro Ala Leu Val Asp Pro Asp Glu Pro Arg Gln Arg Val Thr
85 90 95
Leu Gln Ile Ala Thr Asn Ala Asp Ser Leu Gly Thr Trp Phe Val Glu
100 105 110
Ala Met Ser Asn Phe Ala Lys Ser Ser Ser Tyr Leu Leu Asn Val Ala
115 120 125
Val Asp Asp Gln Ala His Thr Ala Glu Trp Leu Gln Arg Gly Arg Val
130 135 140
Ile Ala Ala Val Thr Ser Leu Glu Lys Pro Val Arg Gly Cys Arg Arg
145 150 155 160
Phe Ala Leu Gly Val Leu Arg Tyr His Ala Thr Ala Thr Pro Asp Phe
165 170 175
Val Thr Ser His Phe Pro Gln Gly Val Thr Ser Glu Ala Ile Arg Asn
180 185 190
Ala Pro Ala Leu Thr Phe Asn Gln Lys Asp Arg Leu Gln Ser Ser Trp
195 200 205
Ile Arg Arg Thr Phe Gly Arg Asp Leu Asp Tyr Pro Thr His Trp Leu
210 215 220
Pro Ser Pro Gln Ser Phe Val Glu Ala Ser Leu Ser Gly Met Gly Trp
225 230 235 240
Gly Met Asn Pro Thr Gln Leu Thr Arg Glu His Leu Ala Ser Gly Arg
245 250 255
Leu Ile Glu Leu Val Pro Asp Thr Pro Leu Asp Val Pro Leu Tyr Trp
260 265 270
Gln Ile Asn Arg Leu Ala Ala Asp Arg Leu Ala Asp Leu Thr Arg Glu
275 280 285
Val Val Thr Val Ala Lys Arg Ser Leu
290 295
<210> 2
<211> 891
<212> DNA
<213> Mesorhizobium tianshanense (Mesorhizobium tianshanense)
<400> 2
atgctcgact atcccgctct tcgcgccgtc gcaactattg tccagacagg cagcttcgaa 60
agagctgcga ccgcgttgaa cgtgacccct tcggccattt cgcagcgcgt gaagcagctc 120
gaggagcgtc tcggcgtcat cctcatcgtc agaggcacgc cgtgcacggc gaccgaaaag 180
ggagaatggc tctgccgcca tatggagaat gtcggcatgc tcgaagcaga actcttcggg 240
caactgcccg ccctcgtcga tcccgacgaa ccacgccaaa gggtcacgct tcaaatcgcg 300
acgaacgccg acagcctcgg aacatggttc gtcgaggcca tgtcgaattt tgccaaaagc 360
tcttcctatc tgctgaacgt cgccgtcgac gaccaggctc ataccgccga atggctgcag 420
cgcggacggg tgatcgccgc cgtcaccagc ctggaaaaac cggtccgagg atgccggcgt 480
tttgccctcg gcgttctgcg ttaccatgca acggcaaccc ccgacttcgt cacaagccat 540
tttccgcagg gcgtaacatc agaggcgatc cgcaacgccc cggcgctgac cttcaatcaa 600
aaggacaggc tgcagagcag ttggatcagg cgaacattcg gacgcgatct cgattatccc 660
acccactggc taccgtcgcc gcagagcttc gtcgaggcga gcctttcagg tatgggatgg 720
ggaatgaacc cgacccagct gacccgcgag cacctcgcat ccggacggct gatcgagctg 780
gtgcccgaca cgccactcga tgtcccgctc tactggcaga taaatcgcct cgccgccgac 840
cgcctggcgg atctgacacg cgaagtcgtc accgtggcca agcgcagcct t 891
<210> 3
<211> 647
<212> DNA
<213> Mesorhizobium tianshanense (Mesorhizobium tianshanense)
<400> 3
tgcccgccct cgtcgatccc gacgaaccac gccaaagggt cacgcttcaa atcgcgacga 60
acgccgacag cctcggaaca tggttcgtcg aggccatgtc gaattttgcc aaaagctctt 120
cctatctgct gaacgtcgcc gtcgacgacc aggctcatac cgccgaatgg ctgcagcgcg 180
gacgggtgat cgccgccgtc accagcctgg aaaaaccggt ccgaggatgc cggcgttttg 240
ccctcggcgt tctgcgttac catgcaacgg caacccccga cttcgtcaca agccattttc 300
cgcagggcgt aacatcagag gcgatccgca acgccccggc gctgaccttc aatcaaaagg 360
acaggctgca gagcagttgg atcaggcgaa cattcggacg cgatctcgat tatcccaccc 420
actggctacc gtcgccgcag agcttcgtcg aggcgagcct ttcaggtatg ggatggggaa 480
tgaacccgac ccagctgacc cgcgagcacc tcgcatccgg acggctgatc gagctggtgc 540
ccgacacgcc actcgatgtc ccgctctact ggcagataaa tcgcctcgcc gccgaccgcc 600
tggcggatct gacacgcgaa gtcgtcaccg tggccaagcg cagcctt 647
<210> 4
<211> 222
<212> PRT
<213> Mesorhizobium tianshanense (Mesorhizobium tianshanense)
<400> 4
Met Pro Ala Leu Val Asp Pro Asp Glu Pro Arg Gln Arg Val Thr Leu
1 5 10 15
Gln Ile Ala Thr Asn Ala Asp Ser Leu Gly Thr Trp Phe Val Glu Ala
20 25 30
Met Ser Asn Phe Ala Lys Ser Ser Ser Tyr Leu Leu Asn Val Ala Val
35 40 45
Asp Asp Gln Ala His Thr Ala Glu Trp Leu Gln Arg Gly Arg Val Ile
50 55 60
Ala Ala Val Thr Ser Leu Glu Lys Pro Val Arg Gly Cys Arg Arg Phe
65 70 75 80
Ala Leu Gly Val Leu Arg Tyr His Ala Thr Ala Thr Pro Asp Phe Val
85 90 95
Thr Ser His Phe Pro Gln Gly Val Thr Ser Glu Ala Ile Arg Asn Ala
100 105 110
Pro Ala Leu Thr Phe Asn Gln Lys Asp Arg Leu Gln Ser Ser Trp Ile
115 120 125
Arg Arg Thr Phe Gly Arg Asp Leu Asp Tyr Pro Thr His Trp Leu Pro
130 135 140
Ser Pro Gln Ser Phe Val Glu Ala Ser Leu Ser Gly Met Gly Trp Gly
145 150 155 160
Met Asn Pro Thr Gln Leu Thr Arg Glu His Leu Ala Ser Gly Arg Leu
165 170 175
Ile Glu Leu Val Pro Asp Thr Pro Leu Asp Val Pro Leu Tyr Trp Gln
180 185 190
Ile Asn Arg Leu Ala Ala Asp Arg Leu Ala Asp Leu Thr Arg Glu Val
195 200 205
Val Thr Val Ala Lys Arg Ser Leu His His His His His His
210 215 220
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011637703.7A CN112661820B (en) | 2020-12-31 | 2020-12-31 | Rhizobium tianshanense transcription regulation protein MsiR mutant protein and application thereof in canavanine biosensor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011637703.7A CN112661820B (en) | 2020-12-31 | 2020-12-31 | Rhizobium tianshanense transcription regulation protein MsiR mutant protein and application thereof in canavanine biosensor |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112661820A CN112661820A (en) | 2021-04-16 |
CN112661820B true CN112661820B (en) | 2021-12-14 |
Family
ID=75413763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011637703.7A Active CN112661820B (en) | 2020-12-31 | 2020-12-31 | Rhizobium tianshanense transcription regulation protein MsiR mutant protein and application thereof in canavanine biosensor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112661820B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114349830B (en) * | 2021-12-16 | 2023-10-03 | 安徽大学 | PhlH protein mutant and application thereof in improving yield of 2,4-diacetyl phloroglucinol |
CN114437186B (en) * | 2022-01-19 | 2023-10-03 | 安徽大学 | A PhlH protein mutant and its application in improving mupirocin production |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL134643A0 (en) * | 1997-08-27 | 2001-04-30 | Ariad Gene Therapeutics Inc | Chimeric transcriptional activators and compositions and uses related thereto |
CN103103167B (en) * | 2013-01-29 | 2015-06-17 | 河北师范大学 | Mutant zymoprotein of D-amino acid oxidase and preparation method of mutant zymoprotein |
CN109536469B (en) * | 2018-11-23 | 2021-02-09 | 北华大学 | Mutation modified Prx6 protein and expression gene, preparation method and application thereof |
CN110283796B (en) * | 2019-08-26 | 2019-11-05 | 中国科学院天津工业生物技术研究所 | MviN protein mutant, the expression vector containing the mutant and host cell and its application |
-
2020
- 2020-12-31 CN CN202011637703.7A patent/CN112661820B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN112661820A (en) | 2021-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111484987B (en) | Heat-resistant DNA polymerase mutant with high amplification activity | |
CN108546698B (en) | an aspartase mutant | |
CN110845622B (en) | Preparation of fusion protein with deletion of different structural domains and application of fusion protein in improvement of protein synthesis | |
CN112661820B (en) | Rhizobium tianshanense transcription regulation protein MsiR mutant protein and application thereof in canavanine biosensor | |
CN112391372A (en) | Glutamic acid decarboxylase mutant, genetic engineering bacterium and application thereof | |
CN113061591A (en) | Novel firefly luciferase mutant, preparation method and application thereof | |
CN111876399A (en) | Arctic-pole-derived beta-glucosidase gene, and encoded protein and application thereof | |
CN108865962B (en) | Escherichia coli engineering bacterium capable of efficiently and soluble expressing 4-alpha-glycosyltransferase | |
CN113736763A (en) | Myrosinase Rmryr and application thereof in preparation of sulforaphane and sulforaphane | |
CN107904222B (en) | A kind of l-amino acid deaminase mutant and its construction method that thermal stability improves | |
CN110218735B (en) | Recombinant acetylcholinesterase fixed on surface of bacillus subtilis | |
CN114438054B (en) | Mutant RNase R and preparation method and application thereof | |
CN114507658B (en) | Enzyme coexpression system and application thereof in synthesizing sialic acid | |
CN109402092B (en) | A marine environment-derived chitinase and its gene | |
CN107794275A (en) | The recombinant yeast pichia pastoris of one kind production (+) gamma-lactams enzyme and its construction method and application | |
CN109943548A (en) | A kind of method for improving the yield of synthetic L-arginine by Corynebacterium blunter | |
CN105755018A (en) | Actinidia arguta L-galactonolactone dehydrogenase gene and expression method thereof | |
CN109880840B (en) | In vivo biotinylation labeling system for recombinant protein escherichia coli | |
WO2009107682A1 (en) | Polynucleotide encoding human-type fc receptor, and method for production of human-type fc receptor utilizing the same | |
CN112574969A (en) | G6PDH mutant and application thereof | |
CN114958933B (en) | A method for preparing radishin using myrosinase Emyr | |
CN115335514A (en) | Biosynthesis of mogrosides | |
CN107841490B (en) | Bifunctional methylenetetrahydrofolate dehydrogenase/cyclase and polyclonal antibodies thereto | |
US11760988B2 (en) | L-aspartate alpha-decarboxylase mutant and application thereof | |
CN111057697A (en) | Heat-resistant TIM barrel protein mutants and their applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |